Analytics

Grace Chang, cofounder and CEO of Kintsugi, says that the use of machine learning voice and biomarker technology can help spot clinical depression and anxiety in regular health discussions.

Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.

Community Health Network EVP and Chief Transformation Officer Dr. Patrick McGill discusses creating seamless and frictionless care delivery and 360-degree understanding of what it's like from a patient, caregiver or clinical outcome perspective.

This follows its earlier approvals from the US, Europe, Japan and Taiwan.

Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.

It delivers ethnicity-specific brain scan analysis within 20 minutes.

Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.

According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.

The company pitches iQuest as a way for physicians to provide more precise cancer treatment and lessen the likelihood of negative side effects.

EchoSolv accurately identifies patients with guideline-defined aortic stenosis using AI.